The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neomile Corporate Advisory Ltd & Neomile Growth ....
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Neomile Corporate Advisory Limited along with Neomile Growth Fund-Series 1 has acquired 46,06,839 equity shares of Anlon Healthcare Ltd, representing 8.67% of the company's total share capital. The shares were purchased through open market transactions between 3rd September 2025 and 5th September 2025. Before this acquisition, the acquirer held Nil shares; after the acquisition, it holds 8.67%. The acquirer is not part of the promoter/promoter group of the company. The disclosure was filed under Regulation 29(1), which is triggered when an acquirer's shareholding crosses the 5% threshold in a financial year. The total equity share capital of Anlon Healthcare stands at 5,31,51,500 shares.
A non-promoter institutional investor building an 8.67% stake signals confidence in the company from external money managers. Shareholders should note this new sizable shareholder and watch whether Neomile increases its stake further toward or beyond the 10% open-offer trigger threshold, which could attract more investor attention to the stock.